WALKER PAUL EDWARD enters TRILLIUM THERAPEUTICS INC. with 5.74M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 1/4/2021ACC: 0001209191-21-000561
Director
Since Jan 2021
5.74M
Baseline shares
0.00
Direct ownership
0 positions
13.04M
Derivative underlying
4 instruments
1
Security positions
5.74M indirect
Non-Derivative Holdings1
Common Shares
IndirectShares owned5.74M
Total
5.74M indirect5.74M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 5.74M | Indirect |
| Total | 5.74M | 5.74M indirect |
Derivative Holdings4
Stock Option (Right to Buy)
DirectUnderlying security
Common Shares
Underlying shares
40K
Shares owned
N/A
Exercise price
12.03
Expiration
—
Exercise window
—
Warrant to Purchase Common Shares
IndirectUnderlying security
Common Shares
Underlying shares
850K
Shares owned
N/A
Exercise price
0.96
Expiration
—
Exercise window
—
Warrant to Purchase Series II Preferred Shares
IndirectUnderlying security
Series II Non-Voting Convertible First Preferred Shares
Underlying shares
5.40M
Shares owned
N/A
Exercise price
0.96
Expiration
—
Exercise window
—
Series II Non-Voting Convertible First Preferred Shares
IndirectUnderlying security
Common Shares
Underlying shares
6.75M
Shares owned
N/A
Exercise price
0.00
Expiration
—
Exercise window
—
Total
Underlying
13.04M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Shares | 12.03 | — | — | 40K | N/A |
| Warrant to Purchase Common Shares Indirect | Common Shares | 0.96 | — | — | 850K | N/A |
| Warrant to Purchase Series II Preferred Shares Indirect | Series II Non-Voting Convertible First Preferred Shares | 0.96 | — | — | 5.40M | N/A |
| Series II Non-Voting Convertible First Preferred Shares Indirect | Common Shares | 0.00 | — | — | 6.75M | N/A |
| Total | 13.04M | 0.00 | ||||